Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals
Xi Wang,1 Debra C DuBois,1,2 Siddharth Sukumaran,2 Vivaswath Ayyar,1 William J Jusko,2,3 Richard R Almon1–3 1Department of Biological Sciences, 2Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY, USA; 3New York State Center of Excellence in Bioinfo...
Main Authors: | Wang X, DuBois DC, Sukumaran S, Ayyar V, Jusko WJ, Almon RR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-11-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Online Access: | http://www.dovepress.com/variability-in-zucker-diabetic-fatty-rats-differences-in-disease-progr-peer-reviewed-article-DMSO |
Similar Items
-
Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
by: Wang X, et al.
Published: (2014-08-01) -
Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice
by: Natalia Marcińczyk, et al.
Published: (2023-01-01) -
Cardiovascular Characteristics of Zucker Fatty Diabetes Mellitus Rats, an Animal Model for Obesity and Type 2 Diabetes
by: Kosuke Otani, et al.
Published: (2022-04-01) -
Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
by: Yi Sui, et al.
Published: (2019-11-01) -
Subclinical hypothyroidism increases insulin resistance in normoglycemic people
by: Wanyu Yang, et al.
Published: (2023-07-01)